Ta V. ID3021 Acquired resistance to with EGFR tyrosine kinase inhibitors by the EGFR T790M mutation in non-small cell lung cancer. BMRAT [Internet]. 5Sep.2017 [cited 7Nov.2024];4(S):S33. Available from: http://bmrat.biomedpress.org/index.php/BMRAT/article/view/243